Hematopoietic Stem Cell Transplantation. Gene and Cellular Therapy.
This meeting was a tribute to Professor Boris Afanasyev, Director of R.M. Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov First State Medical University of St. Petersburg, who was the founder, ideologist and all-time chairperson of the Meeting. AGCT acted as a co-organizer and is endlessly appreciative of the overwhelming response we have received under such unprecedented circumstances.
AGCT was proud to present its latest findings on CCR5-Uco-TALEN safety estimation for CCR5 gene editing in primary human HSC by deep target sequencing approach.
The full session archive available exclusively for the attendees and upon request.
AGCT was excited to share the company’s latest RnD findings at the ASGCT first-ever virtual meeting.